Skip to main content

Table 5 Clinicopathological parameters in correlation with suspLN and N status

From: Relevance of suspicious lymph nodes in preoperative imaging for resectability, recurrence and survival of intrahepatic cholangiocarcinoma

  

suspLN

N statusa

n = 137

yes

no

p-value

N0

N+

p-value

Tumor sizeb

  ≥ 5 cm

99 (72.3%)

38 (27.7%)

61 (44.5%)

0.105

63 (52.1%)

26 (21.5%)

0.236

  < 5 cm

38 (27.7%)

9 (6.6%)

29 (21.2%)

 

19 (15.7%)

13 (10.7%)

 

Multifocal disease

 No – solitary

96 (70.1%)

30 (21.9%)

66 (48.2%)

0.249

56 (46.3)

26 (21.5%)

0.858

 Yes

41 (29.9%)

17 (12.4%)

24 (17.5%)

 

26 (21.5%)

13 (10.7%)

 

Number of nodules

  ≤ 2

105 (76.6%)

32 (23.4%)

73 (53.3%)

0.087

64 (52.9%)

27 (22.3%)

0.294

  ≥ 3

32 (23.4%)

15 (10.9%)

17 (12.4%)

 

18 (14.9%)

12 (9.9%)

 

T status

 T1 + 2

103 (75.2%)

32 (23.4%)

71 (51.8%)

0.165

69 (57%)

20 (16.5%)

< 0.001

 T3 + 4

34 (24.8%)

15 (10.9%)

19 (13.9%)

 

13 (10.8%)

19 (15.7%)

 

UICC stagea

 UICC I + II

67 (55.4%)

10 (8.3%)

57 (47.1%)

< 0.001

67 (55.4%)

–

< 0.001

 UICC III + IV

54 (44.6%)

35 (28.9%)

19 (15.7%)

 

15 (12.4%)

39 (32.2%)

 
  1. a NX patients were excluded (n = 16) or UICC was not applicable; b diameter of largest nodule